Epigenetic processes control the embryonic development into multicellular organisms and
determine the functional differences of genetically identical cells and individuals. They are …

Alpha-synuclein (SNCA) is a major risk gene for Parkinson's disease (PD), and increased
SNCA gene dosage results in a parkinsonian syndrome in affected families. We found that …

Genetic findings have changed our views on Parkinson’s disease (PD) and parkinsonism,
which will be collectively referred to as Parkinsonian Syndrome (PS) in the present manuscript…

Parkinson’s disease (PD) comprises a spectrum of disorders with differing subtypes, the
vast majority of which share Lewy bodies (LB) as a characteristic pathological hallmark. The …

Spinocerebellar ataxia type 3 is a neurodegenerative disease caused by expansion of a
polyglutamine domain in the protein ataxin-3 (ATXN3). Physiological functions of ATXN3 …

Ataxin-3 (AT3), the disease protein in spinocerebellar ataxia type 3 (SCA3), has been
associated with the ubiquitin–proteasome system and transcriptional regulation. Here we report …

Parkinson’s disease affects 5 million people worldwide, but the molecular mechanisms
underlying its pathogenesis are still unclear. Here, we report a genome-wide meta-analysis of …

Ataxin-3 (ATXN3), the disease protein in spinocerebellar ataxia type 3 (SCA3), binds to target
gene promoters and modulates transcription by interaction with transcriptional regulators. …

The nuclear presence of the expanded disease proteins is of critical importance for the
pathogeneses of polyglutamine diseases. Here we show that protein casein kinase 2 (CK2)-…

Background Parkinson’s disease (PD) presently is conceptualized as a protein aggregation
disease in which pathology involves both the enteric and the central nervous system, …